Immunoregulatory sex hormones, including estrogen and estriol, may prevent relapses in multiple sclerosis during pregnancy. Our previous studies have demonstrated that regulatory B cells are crucial for estrogen-mediated protection against experimental autoimmune encephalomyelitis (EAE). Herein, we demonstrate an estrogendependent induction of alternatively activated (M2) macrophages/microglia that results in an increased frequency of regulatory B cells in the spinal cord of estrogen treated mice with EAE. We further demonstrate that cultured M2-polarized microglia promote the induction of regulatory B cells. Our study suggests that estrogen neuroprotection induces a regulatory feedback loop between M2 macrophages/microglia and regulatory B cells.
Introduction
Microglia and macrophages play a pathogenic role in multiple sclerosis (MS) (Sospedra and Martin, 2005) . They are involved in surveying the tissue environment for damage or infections. In the central nervous system (CNS), microglia -which represent 5-12% of brain cells -have similar functions as macrophages in the periphery (Habib and Beyer, 2015; Tay et al., 2016) . Experimental autoimmune encephalomyelitis (EAE), a well-established model of MS, is characterized by extensive lymphocytic infiltration into the CNS. Several reports have demonstrated that monocytes are involved in the exacerbation of EAE, with monocyte depletion resulting in a marked suppression of clinical disease (Bauer et al., 1995; Brosnan et al., 1981; Huitinga et al., 1990) . It has been recently suggested that microglial activation may represent an initial step in EAE pathogenesis, wherein infiltrating monocytes may trigger EAE progression (Ajami et al., 2011) . Depending on the type of stimulation, activated macrophages/microglia can express different cell surface markers and cytokine patterns, suggesting at least two opposing activation states: Classically activated macrophages (M1), present predominantly in the early stages of EAE, can prime inflammatory T cells and recruit them into the CNS. In contrast, alternatively activated macrophages (M2a, b & c) , that appear later in the EAE disease course, inhibit inflammation and promote remyelination by phagocytosis of myelin debris and induction of oligodendrocyte differentiation (Gordon, 2003; Mikita et al., 2011; Miron et al., 2013; Voss et al., 2012) .
Like many other autoimmune diseases, MS predominantly affects females. Of interest, pregnant women with MS may show clinical improvement during the third trimester, often followed by temporary post-partum exacerbations (Confavreux et al., 1998; Vukusic et al., 2004) . These observation suggest that sex hormones, especially estrogen (E2) and estriol (E3) that are dramatically iincreased during late pregnancy, may have immunoregulatory and possibly neuroprotective activities (Bebo et al., 2001; Polanczyk et al., 2006; Wang et al., 2009 ). We demonstrated previously that E2 (17β-estradiol) could induce complete protection against EAE in WT C57BL/6 mice (Offner and Polanczyk, 2006; Polanczyk et al., 2003) . The E2 protective mechanism involved the induction of CD1d hi CD5
+ and other IL-10 and IL-4 secreting regulatory B cells (Bregs) (Matsumoto et al., 2014; Matsushita et al., 2008; Ray et al., 2011) and was dependent upon the interaction of programmed death receptor 1 (PD-1) with its ligand, PDL1 (Bodhankar et al., 2013; Bodhankar et al., 2011; Zhang et al., 2015a) . We further reported that Bregs could affect M2 microglia polarization by enhancing IL-4 secretion (Bodhankar et al., 2015) . However, E2-dependent Breg-microglia interactions during MS/EAE have not yet been fully characterized.
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